Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CLGN
CLGN logo

CLGN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Collplant Biotechnologies Ltd (CLGN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.400
1 Day change
-0.74%
52 Week Range
4.980
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CLGN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock lacks a clear uptrend, has no recent news catalyst, no supportive institutional or insider buying trend, and the options setup reflects extremely high implied volatility with no meaningful directional volume. Since the user is impatient and unwilling to wait for an ideal entry, this is still not an attractive immediate buy. Best current call: hold and avoid initiating a new position now.

Technical Analysis

Current price is 0.405, unchanged from the previous close, with the market showing a slight daily decline. Trend signals are mixed to weak: MACD histogram is slightly positive but contracting, RSI_6 is 40.27, which is neutral-to-weak, and moving averages are converging rather than trending strongly upward. Key levels show pivot at 0.414 with resistance at 0.451 and support at 0.377. That places the stock below the pivot and closer to support than breakout territory, which does not confirm a strong bullish setup. Similar-pattern data suggests limited near-term upside and only modest month-ahead probability.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options activity is not providing a useful bullish signal. Put-call ratios are 0.0 because there is no put open interest or put volume reported, and call open interest is only 65 with zero today’s volume. Implied volatility is extremely elevated at 764.41, with IV percentile at 95.24 and IV rank at 75.01, indicating expensive and unstable option pricing rather than confident directional positioning. Overall, options data shows very low activity and no clear sentiment edge.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
2

Positive Catalysts

  • ["MACD histogram is slightly positive, suggesting a small near-term momentum improvement", "Stock is trading near support rather than extended above resistance", "No adverse news in the recent week"]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh catalyst", "Hedge funds are neutral over the last quarter", "Insiders are neutral over the last month", "No recent congress trading data", "No AI Stock Picker signal today", "No SwingMax signal recently", "Options market shows extremely high implied volatility with no meaningful trading volume", "Price is below the pivot and technicals do not show a strong uptrend"]

Financial Performance

No usable latest-quarter financial snapshot was available due to data error, so there is no reliable quarter-over-quarter growth assessment to support a buy decision. Because the financial data is missing, there is no evidence here of accelerating revenue, profit improvement, or balance-sheet strength that would justify a long-term beginner purchase at this time.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst rating and price-target trend data were not provided. Based on the available evidence, Wall Street sentiment appears neutral rather than bullish: there is no recent positive rating trend, no price-target upgrade narrative, and no visible pro-stock consensus from analysts in the supplied data.

Wall Street analysts forecast CLGN stock price to rise
Analyst Rating
0
Wall Street analysts forecast CLGN stock price to rise
Buy
Hold
Sell
0
Current: 0.405
sliders
Low
0
Averages
0
High
0
0
Current: 0.405
sliders
Low
0
Averages
0
High
0
D. Boral Capital
Jason Kolbert
Buy
to
Hold
downgrade
AI Analysis
2026-02-06
Reason
D. Boral Capital
Jason Kolbert
Price Target
AI Analysis
2026-02-06
downgrade
Buy
to
Hold
Reason
D. Boral Capital analyst Jason Kolbert downgraded CollPlant to Hold from Buy with no price target. The company's recently announced $2M registered direct financing appears to have triggered a "disproportionate response," raising investors concerns, the analyst says.

People Also Watch